WallStSmart
MNMD

Mind Medicine Inc

NASDAQ: MNMD · HEALTHCARE · BIOTECHNOLOGY

$15.02
+1.01% today

Updated 2026-01-14

Market cap
$1.46B
P/E ratio
P/S ratio
EPS (TTM)
$-1.98
Dividend yield
52W range
$5 – $15
Volume
1.9M

Mind Medicine Inc (MNMD) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-26.1%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-188.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+974.6%
Last 8 reports
Positive reaction rate
88%
7 of 8 quarters
Largest single-day move
+1300.3%
2025-05-06
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-11-06$-0.78-56.0%$11.53$11.70+1.5%
2025-07-31$-0.50-35.1%$9.03$8.44-6.5%
2025-05-06$-0.35+34.0%$0.69$9.68+1300.3%
2025-02-26$-0.41-47.2%$0.69$9.68+1300.3%
2024-11-07$-0.27+3.6%$0.69$9.68+1300.3%
2024-08-13$-0.26+21.2%$0.69$9.68+1300.3%
2024-05-08$-1.14-115.1%$0.69$9.68+1300.3%
2024-02-28$-0.59-28.3%$0.69$9.68+1300.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-09-30$-0.50$-0.78-56.0%
2025-06-30$-0.37$-0.50-35.1%
2025-03-31$-0.53$-0.35+34.0%
2024-12-31$-0.28$-0.41-47.2%
2024-09-30$-0.28$-0.27+3.6%
2024-06-30$-0.33$-0.26+21.2%
2024-03-31$-0.53$-1.14-115.1%
2023-12-31$-0.46$-0.59-28.3%$4.84M
2023-09-30$-0.67$-0.45+32.8%
2023-06-30$-0.54$-0.76-40.7%
2023-03-31$-0.42$-0.52-23.8%
2022-12-31$-0.50$-0.16+68.0%

Frequently asked questions

Has Mind Medicine Inc beaten earnings estimates?
Mind Medicine Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -26.1% over the last 4 quarters.
How does MNMD stock react to earnings?
MNMD stock has moved an average of +974.6% in the trading day following earnings over its last 8 reports, with positive reactions in 88% of those quarters.